Show simple item record

dc.contributor.authorMurchie, Peter
dc.contributor.authorMasthoff, Judith
dc.contributor.authorWalter, Fiona M.
dc.contributor.authorRahman, Kazi
dc.contributor.authorAllan, Julia L.
dc.contributor.authorBurrows, Nigel
dc.contributor.authorProby, Charlotte
dc.contributor.authorLee, Amanda J.
dc.contributor.authorJohnston, Marie
dc.contributor.authorDurrani, Amer
dc.contributor.authorDepasquale, Ivan
dc.contributor.authorBrant, Billy
dc.contributor.authorNeilson, Aileen
dc.contributor.authorMeredith, Fiona
dc.contributor.authorTreweek, Shaun P.
dc.contributor.authorHall, Susan J.
dc.contributor.authorMcDonald, Alison M.
dc.date.accessioned2019-06-04T09:30:09Z
dc.date.available2019-06-04T09:30:09Z
dc.date.issued2019-06-03
dc.identifier.citationMurchie , P , Masthoff , J , Walter , F M , Rahman , K , Allan , J L , Burrows , N , Proby , C , Lee , A J , Johnston , M , Durrani , A , Depasquale , I , Brant , B , Neilson , A , Meredith , F , Treweek , S P , Hall , S J & McDonald , A M 2019 , ' Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma : Protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma ' , Trials , vol. 20 , 318 . https://doi.org/10.1186/s13063-019-3453-xen
dc.identifier.issn1745-6215
dc.identifier.otherPURE: 144284472
dc.identifier.otherPURE UUID: 82f02490-0793-432d-a90f-836be9c28003
dc.identifier.otherPubMed: 31159849
dc.identifier.otherScopus: 85066830276
dc.identifier.otherWOS: 000470254100002
dc.identifier.otherMendeley: eb4ef75e-25c7-3c1e-8d39-2eaed9f56338
dc.identifier.otherORCID: /0000-0001-7287-8363/work/78365660
dc.identifier.otherORCID: /0000-0001-9968-5991/work/83704222
dc.identifier.urihttp://hdl.handle.net/2164/12355
dc.identifier.urihttp://www.scopus.com/inward/record.url?scp=85066830276&partnerID=8YFLogxKen
dc.identifier.urihttps://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3453-xen
dc.identifier.urihttp://www.mendeley.com/research/achieving-selfdirected-integrated-cancer-aftercare-asica-melanoma-protocol-randomised-patientfocuseden
dc.descriptionThe authors gratefully acknowledge Joanna Kaniewska, Anne Duncan and Lynda Constable (trial management) for their contributions to the protocol and management of the study. Funding The study is supported by a grant from a Cancer Research UK Population Research Committee project award (C10673/A21685). The views and opinions expressed herein are those of the authors and do not necessarily reflect those of Cancer Research UK. The funder (through their peer review and funding board review process) approved the study proposal but had no role in the collection, analysis, or interpretation of data, or writing of the report.en
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofTrialsen
dc.rights© The Author(s). 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectprimary careen
dc.subjectmelanomaen
dc.subjectcanceren
dc.subjectrandomised controlled trialen
dc.subjectsurvivorshipen
dc.subjectself-directed careen
dc.subjecte-healthen
dc.subjectASICAen
dc.subjectSelf-directed careen
dc.subjectMelanomaen
dc.subjectSurvivorshipen
dc.subjectPrimary careen
dc.subjectRandomised controlled trialen
dc.subjectCanceren
dc.subjectR Medicine (General)en
dc.subjectPharmacology (medical)en
dc.subjectMedicine (miscellaneous)en
dc.subjectCancer Research UKen
dc.subjectC10673/A21685en
dc.subjectSupplementary Dataen
dc.subjectSupplementary data availableen
dc.subject.lccR1en
dc.titleAchieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma : Protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanomaen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Data Safe Havenen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Computing Scienceen
dc.contributor.institutionUniversity of Aberdeen.Medical Educationen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Health Psychology Groupen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Health Economics Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Computer Science and Informaticsen
dc.contributor.institutionUniversity of Aberdeen.Public Health, Health Services and Primary Careen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Medical Statisticsen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s13063-019-3453-x
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85066830276&partnerID=8YFLogxKen
dc.identifier.urlhttps://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3453-xen
dc.identifier.urlhttp://www.mendeley.com/research/achieving-selfdirected-integrated-cancer-aftercare-asica-melanoma-protocol-randomised-patientfocuseden


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record